My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking

Radico Khaitan Ltd Research Report - 21st Jan 2016

Miscellaneous | Published on Nov 10th 2015


For 2QFY2016, Radico Khaitan (RKL)s results have come in above our estimates. The company’s top-line grew by 2% yoy, mainly due to growth in Prestige and above products segment. On the operating front, the company reported margin expansion, primarily on account of lower selling & distribution and other expenses. Further, on the bottom-line front, the company reported a healthy growth due to strong operating performance and lower interest cost. Regular & others products segment de-grew which restricted overall top-line growth but Healthy volume growth in Prestige & above products segment: For the quarter, RKL’s top-line grew by ~2% yoy to ~Rs370cr (our estimate was of ~ Rs364cr), mainly due to healthy volume growth in Prestige and above products segment (up ~8.5%). Prestige and above brands’ contribution to total Indian made foreign liquor (IMFL) volumes increased from 21.2% in 2QFY2015 to 24.7% in 2QFY2016. However, de-growth in Regular & others products segment which contribute more than 75% of total sales, restricted the overall top-line growth of the company. The company is continuously focusing on the Premium products segment to increase sales which is a high margin business. PAT grew ~25% yoy: The reported net profit for the quarter grew by 25% yoy to ~Rs19cr (our estimate was of ~Rs15cr) on account of strong operating performance and lower interest cost (in FY2015 the company has repaid a significant amount of its debt; further debt reduction is also on the cards). Outlook and valuation: RKL has not performed well in the last two years due to increasing material costs (ENA is a key raw material) and with it not receiving significant price hikes from various states. We expect the company to perform well going forward in anticipation of easing material costs and on expectation of better price hikes. This would result in an overall improvement in the operating margin of the company. Also, with the company having reduced significant debt from its balance sheet, it would be able to report an improvement in its profitability. We expect the company to report a strong earnings CAGR of ~18% to ~`95cr over FY2015-17E. Hence, we recommend a Buy rating on the stock with a target price of Rs128.

Download Full Report


CMP 109
Target Price 128
Investment Period12 Months

Stock Info

MCAP BSE (Rs in Cr)Array
MCAP NSE (Rs in Cr)Array
P/E (x)Array
EPS (Rs.)Array
BV (Rs.)Array
Div Yield (%)Array
FV (Rs.)Array
P/BV (x)Array
EV/Sales (x)Array
EV/EBITDA (x)Array

Shareholding Pattern (%)

Public & Others20.0
Grand Total100.0

Trade Securely


Portfolio Tracking & Trading Application View Demo